Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Do not call
En
Senores Pharmaceuticals Ltd. Share Price
Day's Range
Low
₹1,165.00
High
₹1,227.00
Price Summary
| Previous Close | ₹1,174.60 |
|---|---|
| Day's Range | ₹1,165.00 - ₹1,227.00 |
| Open | ₹1,208.00 |
| 52 Week Range | ₹706.00 - ₹1,599.00 |
| Volume | 4,09,497 |
| Market Cap | ₹0.01 |
| Previous Close | ₹1,174.70 |
|---|---|
| Day's Range | ₹1,166.60 - ₹1,226.20 |
| Open | ₹1,215.80 |
| 52 Week Range | ₹708.10 - ₹1,599.55 |
| Volume | 16,379 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 4,839.38 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 40.53 |
| TTM EPS (₹) | 28.98 |
| P/E Ratio | 30.25 |
| Book Value(₹) | 5.39 |
| PAT Margin (%) | 19.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 15.66 |
| Trade Value ( ₹ in Lacs) | 194.11 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 40.53 |
| TTM EPS (₹) | 28.98 |
| P/E Ratio | 30.25 |
| Book Value(₹) | 5.39 |
| PAT Margin (%) | 19.21 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 15.66 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 280.1 | 385.4 |
| Expenses | N/A | N/A |
| PBT | 76.6 | 51.1 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 64.3 | 36.9 |
About Senores Pharmaceuticals Ltd.
| Founded | 2017 |
|---|---|
| Managing Director | Swapnil Jatinbhai Shah |
| NSE Symbol | SENORES |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,290.91 | 1,880.90 | 1,583.70 - 1,583.70 |
| Divi's Laboratories Ltd. | 3,05,014.11 | 11,489.65 | 5,647.50 - 5,647.50 |
| Torrent Pharmaceuticals Ltd. | 1,77,333.20 | 4,662.15 | 3,672.30 - 3,672.30 |
| Laurus Labs Ltd. | 1,30,755.56 | 2,420.00 | 917.95 - 917.95 |
| Lenskart Solutions Ltd. | 1,26,550.66 | 726.30 | 0.00 - 0.00 |
| Apollo Hospitals Enterprise Ltd. | 1,22,439.82 | 8,515.50 | 6,696.50 - 6,696.50 |
| Zydus Lifesciences Ltd. | 1,18,802.71 | 1,191.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,15,016.89 | 1,377.00 | 1,101.00 - 1,101.00 |
| Cipla Ltd. | 1,12,538.81 | 1,393.00 | 1,165.70 - 1,165.70 |
| Mankind Pharma Ltd. | 1,09,622.17 | 2,654.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Senores Pharmaceuticals informs about newspaper publications
Senores Pharmaceuticals informs about newspaper publication
Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Senores Pharmaceuticals has informed that it enclosed copies of Newspaper Publications as published, in Financial Express -English and Gujarati Edition, on October 17, 2026, regarding completion of dispatch of Notice of Postal Ballot, intimation of e-voting and other related information. This intimation is also being uploaded on the website of the Company: www.senorespharma.com.
The above information is a part of company’s filings submitted to BSE.
Natco Pharma - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 8545.00 | 12643.00 | -32.41 | 14511.00 | 24570.00 | -40.94 | 35946.00 | 40945.00 | -12.21 |
| Other Income | 403.00 | 933.00 | -56.81 | 886.00 | 1529.00 | -42.05 | 2811.00 | 3213.00 | -12.51 |
| PBIDT | 2566.00 | 6458.00 | -60.27 | 4109.00 | 12451.00 | -67.00 | 15860.00 | 24656.00 | -35.67 |
| Interest | 156.00 | 117.00 | 33.33 | 252.00 | 143.00 | 76.22 | 323.00 | 196.00 | 64.80 |
| PBDT | 2410.00 | 6341.00 | -61.99 | 3857.00 | 12308.00 | -68.66 | 15537.00 | 24460.00 | -36.48 |
| Depreciation | 440.00 | 481.00 | -8.52 | 867.00 | 1019.00 | -14.92 | 1896.00 | 2200.00 | -13.82 |
| PBT | 1970.00 | 5860.00 | -66.38 | 2990.00 | 11289.00 | -73.51 | 13641.00 | 22260.00 | -38.72 |
| TAX | 538.00 | 851.00 | -36.78 | 812.00 | 1639.00 | -50.46 | 826.00 | 3756.00 | -78.01 |
| Deferred Tax | 314.00 | -455.00 | -169.01 | 478.00 | -727.00 | -165.75 | -1858.00 | -319.00 | 482.45 |
| PAT | 1432.00 | 5009.00 | -71.41 | 2178.00 | 9650.00 | -77.43 | 12815.00 | 18504.00 | -30.74 |
| Equity | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 | 358.00 | 358.00 | 0.00 |
| PBIDTM(%) | 30.03 | 51.08 | -41.21 | 28.32 | 50.68 | -44.12 | 44.12 | 60.22 | -26.73 |
Park Medi World - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 340.54 | 229.69 | 48.26 | 675.86 | 459.38 | 47.12 | 1289.65 | 915.82 | 40.82 |
| Other Income | 41.70 | 2.00 | 1985.00 | 88.38 | 4.01 | 2103.99 | 103.35 | 20.70 | 399.28 |
| PBIDT | 54.72 | 105.50 | -48.13 | 114.24 | 211.02 | -45.86 | 627.05 | 261.09 | 140.17 |
| Interest | 17.23 | 32.97 | -47.74 | 25.83 | 65.95 | -60.83 | 127.55 | 123.43 | 3.34 |
| PBDT | 37.49 | 72.53 | -48.31 | 88.41 | 145.07 | -39.06 | 499.50 | 137.66 | 262.85 |
| Depreciation | 43.61 | 11.62 | 275.30 | 77.42 | 23.23 | 233.28 | 45.09 | 48.62 | -7.26 |
| PBT | -6.12 | 60.91 | -110.05 | 10.99 | 121.84 | -90.98 | 454.41 | 89.04 | 410.34 |
| TAX | 0.45 | 11.95 | -96.23 | 6.72 | 23.91 | -71.89 | 88.25 | 17.24 | 411.89 |
| Deferred Tax | -2.59 | -0.13 | 1892.31 | 0.24 | -0.26 | -192.31 | -24.50 | -20.83 | 17.62 |
| PAT | -6.57 | 48.96 | -113.42 | 4.27 | 97.93 | -95.64 | 366.16 | 71.80 | 409.97 |
| Equity | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 | 863.86 | 768.80 | 12.36 |
| PBIDTM(%) | 16.07 | 45.93 | -65.02 | 16.90 | 45.94 | -63.20 | 48.62 | 28.51 | 70.55 |
KMC Speciality Hosp. - Quaterly Results
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202609 | 202509 | % Var | 202609 | 202509 | % Var | 202603 | 202503 | % Var | |
| Sales | 929.37 | 749.02 | 24.08 | 1847.14 | 1414.55 | 30.58 | 3057.68 | 2315.98 | 32.03 |
| Other Income | 14.58 | 12.44 | 17.20 | 32.66 | 20.45 | 59.71 | 50.76 | 30.86 | 64.48 |
| PBIDT | 297.61 | 220.89 | 34.73 | 600.54 | 393.41 | 52.65 | 930.02 | 599.71 | 55.08 |
| Interest | 19.31 | 20.45 | -5.57 | 39.34 | 42.09 | -6.53 | 83.07 | 94.16 | -11.78 |
| PBDT | 278.30 | 200.44 | 38.84 | 561.20 | 351.32 | 59.74 | 846.95 | 505.55 | 67.53 |
| Depreciation | 61.92 | 53.04 | 16.74 | 120.44 | 103.86 | 15.96 | 216.71 | 189.52 | 14.35 |
| PBT | 216.38 | 147.40 | 46.80 | 440.76 | 247.46 | 78.11 | 630.24 | 316.03 | 99.42 |
| TAX | 54.15 | 38.99 | 38.88 | 112.80 | 63.70 | 77.08 | 162.89 | 101.76 | 60.07 |
| Deferred Tax | -2.95 | 5.24 | -156.30 | -7.21 | -0.90 | 701.11 | 3.77 | 28.68 | -86.85 |
| PAT | 162.23 | 108.41 | 49.64 | 327.96 | 183.76 | 78.47 | 467.35 | 214.27 | 118.11 |
| Equity | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 | 163.08 | 163.08 | 0.00 |
| PBIDTM(%) | 32.02 | 29.49 | 8.59 | 32.51 | 27.81 | 16.90 | 30.42 | 25.89 | 17.46 |
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Senores Pharmaceuticals Ltd. is ₹1,174.60 as of 2026-11-13.
The market capitalisation of Senores Pharmaceuticals Ltd. is ₹5,409.91 as of 2026-11-13.
The 1-year return of Senores Pharmaceuticals Ltd. is 381.90% as of 2026-11-13.
The P/E ratio of Senores Pharmaceuticals Ltd. is 30.25 as of 2026-11-14.
The 52-week high and low of Senores Pharmaceuticals Ltd. are ₹1,599.00 and ₹706.00, respectively, as of 2026-11-13.
People Also Ask
Senores Pharmaceuticals Ltd. is an Indian pharmaceutical company engaged in the development and manufacturing of pharmaceutical products. Its business includes complex generics, specialty products, critical care injectables, formulations and Active Pharmaceutical Ingredients (APIs) for regulated and emerging markets.
Senores Pharmaceuticals Ltd. develops, manufactures and supplies pharmaceutical products across different therapeutic areas and dosage forms. Its business includes complex generics, branded generics, critical care injectables and APIs for markets including the US, Canada and emerging countries.
Senores Pharmaceuticals Ltd. was incorporated as Senores Pharmaceuticals Private Limited on December 26, 2017, in India. The company was converted into a public limited company effective September 5, 2023, and its shares were listed on the Indian stock exchanges in December 2024.
Senores Pharmaceuticals Ltd. operates in the pharmaceutical industry. Its business activities include the development and manufacturing of pharmaceutical formulations, complex generics, injectables and Active Pharmaceutical Ingredients, along with the trading of pharmaceutical and allied products.
Senores Pharmaceuticals Ltd.'s business activities include pharmaceutical product development and manufacturing, contract development and manufacturing, API manufacturing and the supply of pharmaceutical products. The company also operates businesses involving branded generics and pharmaceutical formulations for regulated and emerging markets.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
